IMBEVLI Trademark

Trademark Overview

On Monday, May 31, 2021, a trademark application was filed for IMBEVLI with the United States Patent and Trademark Office. The USPTO has given the IMBEVLI trademark a serial number of 90744615. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Monday, May 13, 2024. This trademark is owned by Soleno Therapeutics, Inc.. The IMBEVLI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations to treat Prader-Willi syndrome
imbevli

General Information

Serial Number90744615
Word MarkIMBEVLI
Filing DateMonday, May 31, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateMonday, May 13, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 5, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations to treat Prader-Willi syndrome

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 24, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSoleno Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRedwood City, CA 94065
Party NameSoleno Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRedwood City, CA 94065

Trademark Events

Event DateEvent Description
Thursday, June 3, 2021NEW APPLICATION ENTERED
Tuesday, August 24, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, February 14, 2022ASSIGNED TO EXAMINER
Monday, February 14, 2022NON-FINAL ACTION WRITTEN
Monday, February 14, 2022NON-FINAL ACTION E-MAILED
Monday, February 14, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, February 28, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, February 28, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 1, 2022ASSIGNED TO LIE
Tuesday, March 1, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 2, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 2, 2022LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, March 16, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 5, 2022PUBLISHED FOR OPPOSITION
Tuesday, April 5, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 31, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, October 26, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, October 26, 2022SOU EXTENSION 1 FILED
Wednesday, October 26, 2022SOU EXTENSION 1 GRANTED
Friday, October 28, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 30, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, May 30, 2023SOU EXTENSION 2 FILED
Tuesday, May 30, 2023SOU EXTENSION 2 GRANTED
Thursday, June 1, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 30, 2023SOU TEAS EXTENSION RECEIVED
Thursday, November 30, 2023SOU EXTENSION 3 FILED
Thursday, November 30, 2023SOU EXTENSION 3 GRANTED
Friday, December 1, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 13, 2024SOU EXTENSION 4 FILED
Monday, May 13, 2024SOU EXTENSION 4 GRANTED
Monday, May 13, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, May 14, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

imbevli willi syndrome prader treat preparations pharmaceutical